Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Crown Bioscience

3003 Bunker Hill Lane Ste 104
Santa Clara, CA 95054
Website Company Summary Management Team

CEO: Alex Wu
President/COO/Operations: Faming Zhang (2008) ; William Pan
General Management: Chuan Shih; Meng Yang (02/01/2007)
Technology: Yiyou Chen
Business Development: Jean-Pierre Wery
Former Employees: Felix Lin


Business description: Crown Bioscience is a California, USA headquartered company that adds value to the global pharmaceutical and biotechnology industry by enhancing its research and development productivity. Crown Bioscience (Beijing) is a fully owned subsidiary of Crown Bioscience and serves as its operational base in China. As our customers and partners are global, world-class enterprises in North America, Europe and Asia, we set our goal to be a company with a global vision and with the highest standard in the world. Our core values are integrity, diligence and reliability. We view our employees as our most valuable assets and will treat them as such. In return, we expect them to share our core values and contribute to the growth of the company. By catching the global outsourcing tide, a historical and irrevocable development, Crown Bioscience is expected to grow at a breathtaking speed, providing tremendous opportunities for our employees to learn and prosper, both personally and professionally.
Partners include: Shanghai Tigermed Consulting

Rounds: 3
Recent Fundings: May 2011   Sep 2008
Capital raised: 41.5M
Last Round: 28.8M
Ownership: Private  
VCs include: Acorn CampusTelegraph Hill PartnersIgnition PartnersOrbiMedHarbinger Venture Management;  CDIB;  Argonaut Private Equity;  CID Group;  Harbinger Qiming Venture Partners;  Saints Ventures;  IBT
Corporate investors: Boston Scientific

Last Tweets


Last Mentions

Record updated: May 2011
Sector: Biotech
Rounds: 3
Recent Fundings: May 2011   Sep 2008
Capital Raised: 41.5M
Last Round: 28.8M
Ownership: Private